×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS34: Impact of COVID-19 on US Clinical Studies Conducted by Japan-Based Pharmaceutical Companies
Session Chair(s)
Kazumi Taguchi, MSc
Entrepreneur in Residence
Astellas Pharma, Japan
Speaker(s)
Yu Tanaka
Project Planning & Management Forum NY Chapter, United States
Project Manager
Takahiro Yoshida
MSD, Japan
Clinical Research Specialist, Study Operation
Have an account?